OBJECTIVE: Myelomeningocele (MMC) is a congenital disease which can leave irreversible neurological sequelae after birth. Due to the significant maternal and fetal complication of open fetal surgery, tissue engineering with fetoscopic approach has the potential to provide a less invasive approach for fetal therapy. Our study focuses on the development and characterization of the physical and biological properties of visible light-cured glycol chitosan (GC) hydrogels, which is applicable in wet condition without suture or glue, for fetoscopic MMC prenatal repair. STUDY DESIGN: Visible light-cured GC hydrogels were prepared and characterized. Then it was applied prenatally to retinoic acidinduced fetal MMC in the rat model.
OBJECTIVE: Fetal myelomeningocele (MMC) repair has proven postnatal benefits with the disadvantage of premature birth and obstetric complications related to hysterotomy as demonstrated in the Management of Myelomeningocele Study (MOMS). Performing the neurosurgical closure fetoscopically aims to avoid the uterine legacy created by hysterotomy but must produce comparable postnatal outcomes to be considered an equivalent alternative. We report the obstetric and early neonatal outcomes of fetoscopic MMC repair for our initial cases related to the MOMS benchmarks. STUDY DESIGN: This is a pilot trial of an open two-port fetoscopic approach for fetal MMC repair, aimed to evaluate feasibility and safety in a newly established program. Participants with isolated fetal MMC between 19-25+6 weeks gestation with preserved lower leg function in addition to MOMS inclusion criteria were prospectively enrolled in a FDA monitored study (clinical trial: NCT03090633). Outcome follow-up mirrors the MOMS trial design. Obstetric and early infant outcomes are reported. RESULTS: Ten of 18 screened women with isolated fetal MMC (upper border from L2-S1) had fetoscopic repair at 24+6 weeks gestation (range 22+6-25+5). 9 cases, had successful fetoscopic primary closure. One procedure was a hybrid, requiring conversion to hysterotomy for completion. Skin-to-skin surgical time was 345 minutes (range 280-458). Fetoscopy time was 210 minutes (range 127 -289). Prenatally, hindbrain herniation improved in 9/10. Two had preterm premature rupture of membranes at 30+5 and 32+4 weeks. To date, 5/8 had an uncomplicated vaginal delivery and 3/8 underwent cesarean delivery for standard obstetric indications. Median gestational age at delivery was 36+6 weeks (range 29+6-39+6). Two remain undelivered, both beyond 32 weeks. All surgical closures were well-healed at birth (Figure 1 ). To date, no infants have required intervention or shunt for hydrocephalus at ages 2-14 months (Figure 2) . CONCLUSION: Open two-port fetoscopic fetal MMC repair appears surgically equivalent to open fetal surgery with favorable obstetric outcomes despite long operative times. Our early outcomes meet the perinatal benchmarks that have demonstrated benefit for prenatal repair established by the MOMS trial with the encouraging benefit of subsequent vaginal delivery.
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